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Xenopus laevis oocytes provide an efficient translation system for microinjected, 
beterologous mRNAs. They offer several advantages over conventional in vitro 
translation systems since oocytes can perform postranslational processes such as 
proteolytic cleavage, glycosylation, sequestration, and secretion of products (1- 
3).  Translation  products  have  been  detected  in  whole  oocyte  extracts  and 
secretory proteins have been found in the culture medium of the oocytes (4-7). 
The acetylcholine receptor, an integral membrane protein, was found associated 
with a  membrane  fraction  of oocyte extracts  (4).  Oocyte translation products 
have been detected by their biologic activity (6),  enzymatic activity (8), and by 
biosynthetic labeling with radioactive precursors followed by immunoprecipita- 
tion (4, 7).  We are interested in the expression of Fc receptors and their genetic 
organization. Fc receptors (FcR) are a group of plasma membrane proteins that 
bind the Fc domain of immunoglobulin (Ig). These receptors are expressed by 
many cells of the immune system (9), are in many instances inducible (10), and 
differ  in  their  specificity  for  different  isotypes  of  Ig.  We  report  here  that 
translated mammalian plasma membrane receptors can be detected by binding 
of labeled ligands or monoclonal anti-receptor antibodies on the oocyte plasma 
membrane. This assay affords a sensitive and rapid method for the detection of 
rare mRNA species that code for plasma membrane proteins. 
Materials and Methods 
Cell Lines.  The  murine macrophage-like cell  line J774  and  the  T  cell  lymphoma 
L5178Y were grown in Dulbecco's medium containing 5% fetal bovine serum (FBS); the 
rat basophilic cell line RBL-1 was cultured in alpha-modified minimum essential medium 
and  10% FBS; the human promonocytic cell line U937 was grown in RPMI  1640  with 
10%  FBS. All lines were grown in spinner culture in media supplemented with 2 mM 
glutamine, 5 t~g/ml gentamycin, 100 U/ml penicillin, and 10 ~g/ml streptomycin. 
Immunoglobulins.  The IgG of 2E2A and the Fab fragment of the monoclonal anti- 
FCv2b/.r;R IgG, 2.4G2, were prepared as described (11,  12). Rat IgE from the IR-162 
myeloma was kindly provided by Dr. H. Metzger (National Institutes of Health) and the 
mouse IgE was prepared as described (13).  Mouse IgG2a was purified from the ascites 
fluid of mice bearing the LPC-1  myeloma by ammonium sulfate precipitation and DE-52 
ion exchange chromatography. The F(ab')2 fragment of mouse IgG2a was prepared by 
pepsin digestion and isolated by high performance liquid chromatography gel filtration. 
Proteins were iodinated using iodogen (Pierce Chemical Co., Rockford, IL) (12). 
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Isolation of mRNA.  RNA was isolated by extraction with guanidine thiocyanate (14) 
from cells grown in spinner culture. Poly(A)  + mRNA was selected by affinity chromatog- 
raphy on oligo-dT cellulose. 
Xenopus Oocyte Assays.  Isolated oocytes (15) were incubated for 2 h at room tempera- 
ture with gentle agitation in Ca++-free OR-2 saline containing 2 mg/ml collagenase (Type 
1A; Sigma Chemical Co., St. Louis, MO) and were then rinsed with half-strength L-15 
medium (Gibco Laboratories, Grand Island, NY) supplemented with 100 U/ml of peni- 
cillin, 5/~g/ml of gentamycin, and 10 mM Hepes, pH 7.4. The oocytes were injected with 
60 nl of mRNA (usually 1 mg/ml) in water and incubated for 2 d in half strength L-15. 
For binding assays, the oocytes were incubated for 1 h at room temperature in medium 
containing ~2~I-ligand (1 #g/ml, 104 cpm/ng protein) and [14C]sucrose (0.67 mM sucrose, 
3.7  mCi/mmole;  New England  Nuclear, Boston, MA).  After washing, oocytes showing 
intact animal/vegetal pole morphology were individually assayed for  l~sI in  a  gamma 
counter, and the oocytes were then prepared for scintillation counting by the addition of 
0.1  ml of 0.5 M NH~OH and 2 ml of Hydroflour (New England Nuclear). The high end 
of the  14C spectrum was assayed, and the results corrected for 1% spillover of 12~I into 
the  14C  channel.  Oocytes that  took  up  more  [~4C]sucrose  than  the  mean  plus  3  SD 
incorporated by control oocytes were considered nonviable, and were disregarded. Bind- 
ing of ligand was scored as positive if the amount of ~SI-ligand bound was >3 SD above 
the mean bound by controls. The stimulation index was calculated as: experimental cpm 
bound/average control cpm bound. 
Results and  Discussion 
Expression  of Murine Fc~2b/vlR on Oocytes.  The J774  mouse macrophage cell 
line expresses a  receptor that binds mouse  IgG2b and  IgG1  aggregates (Fc.r2b/ 
~R)  (11).  Poly(A)  ÷ mRNA  isolated from the  FC~b/vlR-positive J774  and  Fc.r2b  / 
~lR-negative L5178Y cell lines was injected into Xenopus oocytes (Fig.  1) and 2 
d  later  the  binding  to  oocytes of ~25I-2.4G2  Fab,  a  monoclonal antibody  that 
binds to Fc~2b/~lR  (11), was measured.  To control for nonviable oocytes, which 
trap ligand nonspecifically, [14C]sucrose, an impermeant tracer, was added to the 
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FIGURE  I.  Expression of FC~b/~lR by oocytes injected with J774 mRNA. The oocytes were 
injected with 60 nl of poly(A)  + mRNA (1 mg/ml, dissolved in water) isolated from J774 (0) or 
L5178Y cells (O), incubated for 2 d, and assayed as described in Materials and Methods. 608  PURE  ET  AL.  BRIEF  DEFINITIVE  REPORT 
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FIGURE 2.  Kinetics and dose dependence of Fcv2b/~R in oocytes injected with J774 mRNA. 
(A) Oocytes were injected with 60 nl ofJ774  mRNA at different concentrations, incubated 
for 2 d, and assayed as described in Materials and Methods. (B) Kinetics of Fc~,b/~, R expression 
by oocytes injected with J774 mRNA. Oocytes were injected with 60 ng ofJ774 mRNA and 
20 experimental oocytes and control oocytes were assayed at each time interval for l~sI-2.4G2 
Fab binding. Data in panels A and B are from different experiments. 
mRNA from the  Fcv2b/~lR-positive  cell  line bound  125I-2.4G2 Fab  specifically 
(Fig.  1). Those oocytes injected with mRNA from L5178Y (an FcR-negative T 
cell line) that  bound  125I-2.4G2  Fab  also took up  [14C]sucrose,  demonstrating 
that these oocytes were nonviable and that uptake of iigand was thus nonspecific. 
Binding of ~5I-2.4G2 Fab was detected after the injection of as little as 120 pg 
of mRNA per oocyte and was dependent on the amount of mRNA injected (Fig. 
2A). The percentage of oocytes binding ~25I-2.4G2 Fab over background levels 
reached a plateau at 70% with 6 ng of injected mRNA (data not shown), and the 
amount of receptor per oocyte generally began to plateau at 30-60 ng of mRNA 
(Fig. 2A). Receptor expression was detectable 24 h after injection and increased 
until  day  3  (Fig.  2B).  The  binding  of 125I-2.4G2  Fab  was  inhibited  by  the 
presence of an excess of unlabeled 2.4G2 Fab (data not shown). 
We investigated whether radiolabeled monoclonal antibodies specific for J774 
cell surface proteins other than FcR were bound by oocytes injected with J774 
mRNA. J25I-2E2A, a monocional IgG directed against a major 82,000 Mr plasma 
membrane protein  (12)  found on J774  cells (6  ×  105  sites per cell), binds  to 
oocytes injected with J774 mRNA. The percentage of oocytes binding 125I-2.4G2 
Fab and  125I-2E2A over background levels was 80 and 65%,  respectively. The 
average stimulation index was 5.4 +  3.2 for 125I-2E2A Fab and 20 +  11 for 125I- 
2.4G2 Fab. These data indicate that binding of monoclonal antibodies to oocyte 
plasma membranes is likely to be a general method for the study of cell surface 
components. 
Expression of Functional Rat Fc~R on Oocytes.  We next investigated the appli- 
cability of the oocyte system to translation of other Fc receptors for which we 
had  no  monoclonal antibody probe.  The  RBL-1  rat  basophilic  leukemia line 
(2H3 subline) expresses a  high avidity receptor for IgE (Fc,R) (16).  Individual 
oocytes injected with RBL-1  mRNA bound as much as 22,000  cpm of 125I-IR- 
162 rat IgE, compared with an average of 215 _+ 36 cpm bound to water-injected 
oocytes (Fig.  3A  and B).  Comparable  data  were obtained  with  a  mouse  IgE 
hybridoma (13) (data not shown), indicating that the Fc,R bound the IgE by the 
Fc  domain  and  not  the  antigen-combining  site.  Furthermore,  as  might  be 
predicted by the absence of high avidity Fc~R on J774 cells, ~25I-rat IgE did not PURE  ET  AL.  BRIEF  DEFINITIVE  REPORT  609 
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FIGURE 3.  Binding of ~5I-ligands by oocytes injected with mRNA from RBL-1  and U937 
cells. Oocytes injected with RBL-1 mRNA (A) or water (B) were assayed with l~I-IR-162 IgE 
myeloma protein (1 #g/ml,  104 cpm/ng) (A, B). Oocytes injected with U937 mRNA (C-E) or 
125  4  water (F) were assayed with  I-LPC-1  IgG2a myeloma protein (1 #g/ml, 10  cpm/ng) (C, F), 
or t25I-LPC-1 plus 2/~g/ml of unlabeled LPC-1 (D), or 2 #g]ml of LPC-1 F(ab')2 fragment (E). 
St, stimulation index. 
bind to J774 mRNA-injected  oocytes (data not shown). It is apparent that the 
Fc,  R on the oocyte plasma membrane was in a conformation that fulfilled the 
requirements for ligand binding. 
Expression  of Functional Human Fc.~Rhi on Oocytes.  The human monocyte-like 
cell line U937  has a  high affinity receptor  for IgG (Fc~Rhi), the expression of 
which is amplified by the addition of y-interferon  (y-IFN)  (17)  (Table I).  We 
prepared mRNA from untreated and y-IFN-treated U937 cells for injection into 
oocytes.  The oocytes were able to express functional human Fc~Rhi, as demon- 
strated  by binding of lu~I-IgG2a  to oocytes  injected with mRNA  from y-IFN- 
treated  U937  cells (Table  I and Fig.  3 C).  Remarkably, the density per #m 2  of 
FcsRhi is comparable on the y-IFN-induced U937 cells and the oocytes injected 
with mRNA isolated from these cells (Table I). The binding of 1 t~g/ml of lusI- 
IgG2a was inhibited 60% by 2 t~g/ml of unlabeled IgG2a, but not by the F(ab')2 
fragment  (Fig.  3,  D  and E).  However,  10-fold  less  binding of l~sI-IgG2a  was 
observed on oocytes injected with mRNA from untreated U937 cells compared 
with y-IFN-treated  U937  cells (Table  I),  which suggests that the treatment  of 
the U937 cells with 3,-IFN results in induction of new mRNA coding for FcsRhi. 
The  results  presented  here  demonstrate  that  oocytes  efficiently  synthesize 
heterologous plasma membrane proteins and are capable of expressing them in 
a functional conformation on the plasma membrane. Similar results have recently 
been reported  by Gunderson et al.  (18),  who showed that injection of mRNA 
from human brain into oocytes induced the appearance of receptors and channels 610  PURE  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  1 
Effect of "~-IFN on the Expression of Fc~Rh~ 
U937 cells  Oocytes injected with 
mRNA from U937 cells 
Untreated  y-IFN-  Untreated  3,-IFN- 
induced  induced 
Fc~Rh~ per cell*  8x  10  a  7x  I04  5x  10  v  6x  108 
FcvRhi per t~m  ~  cell surface*  8  69  9.7  113 
U937  cells grown in  spinner (3-4  x  105  cells/ml)  were  treated  with  100  U/ml  of 
recombinant y-IFN. Cells were assayed or mRNA prepared after  18 h.  Binding  studies 
on U937  cells were performed at 25°C as described  (17) using iodinated  IgG2a mouse 
myeloma protein LPC-1 (1 ~g/ml; 8 x  l0 s cpm/ng). Oocytes injected  with mRNA were 
•  •  12~  also assayed for binding of  I-LPC-1. In reticulocyte  lysates, both mRNA preparations 
catalyzed the synthesis of high Mr proteins,  indicating  that the mRNA preparations were 
of good quality. 
•  Data were corrected by subtraction  of binding to the FcR-negative cell line MOLT-4  or 
L5178Y and uninjected  oocytes, 
• The approximate surface areas of the cells were calculated from their diameters. 
in the oocyte membrane. Many monoclonal antibodies (including 2.4G2 IgG) do 
not immunoprecipitate reticulocyte lysate translation products. Since the Fc,2b/ 
~tR  message is  rare,  it  is  difficult to  immunoprecipitate FC~b/,1R  from [3~S]- 
methionine-labeled oocyte lysates. The screen for ligand or monoclonal antibody 
binding to  the oocyte surface is a  rapid and sensitive assay for minor mRNA 
species, and the method promises to be of great utility for the molecular analysis 
of membrane receptors by both their ligand binding and antigenic properties. 
Summary 
We  report  that  Xenopus  laevis  oocytes  can  efficiently translate  and  insert 
heterologous membrane receptors into the oocyte plasma membrane, where they 
can be detected by the binding of either monoclonal antibodies or ligands. Thus, 
oocytes injected with mRNA from the mouse J774 macrophage-like cell line, the 
rat  RBL-1  basophilic  leukemia,  and  the  U937  promonocyte cell  line,  bound 
2.4G2  Fab,  rat  IgE, and mouse IgG2a,  respectively. The increase in the high 
avidity Fc,R observed after 3,-interferon induction of U937  cells was also ob- 
served  after  injection  of mRNA  from  3,-interferon-induced  U937  cells  into 
oocytes. This suggests either much greater message stability or a greater rate of 
transcription  of  Fc~Rhi mRNA  in  the  3,-interferon-induced  cells.  The  assay 
affords a sensitive method for the detection of rare mRNA species that code for 
plasma membrane proteins. 
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